Brussels, 19 February 2026 – Burson, the global communications agency purpose-built to create value for clients through reputation, today announced the appointment of Emmanuel Chantelot as Managing Director, Healthcare and Corporate Advisory. In this role, Chantelot will play a key role in serving and growing the agency’s clients in the healthcare sector and strategic advisory services, helping clients navigate complex policy, reputation and business challenges. Based in Brussels, he will work closely with Burson’s Health & Wellness and Corporate and Public Affairs (CPA) teams globally.
Emmanuel Chantelot joins Burson with 30 years of experience in international public affairs, including two decades in healthcare during which he held leadership roles in four global biopharmaceutical companies. In his most recent position as Pfizer’s Vice President and Head of Global Markets Policy & Public Affairs, he advocated for Pfizer’s public policy positions and priorities across all international markets outside the US and oversaw Pfizer’s regional and country public affairs teams.
Prior to his role at Pfizer, Chantelot was Vice President and Head of International Policy & Government Affairs at Bristol Myers Squibb, and had senior roles at Celgene, Shire and EFPIA, the European pharmaceutical industry federation. Earlier on, Chantelot served as chief executive of WLPGA, a Paris-based global oil and gas industry association, and worked at Eurometaux representing the non-ferrous metals sector towards EU institutions.
Andrew Cecil, CEO of Burson Brussels, said: "We are delighted to welcome Emmanuel to Burson. His global corporate experience at the intersection of business and policy, coupled with his deep expertise in the healthcare sector, will be particularly valuable to our clients during this unprecedented period where geopolitics and trade impact their business across Europe."
Tamsin Tierney, Group Managing Director, Health & Wellness, Burson UK, added: "Emmanuel's outstanding experience and leadership in global and market-level healthcare public affairs and policy will be a tremendous asset to our UK team and our clients. We are incredibly excited to have him join the team and collaborate closely to drive even greater impact and innovation across the region’s fast-changing healthcare landscape."
“I am thrilled to join Burson to work alongside a talented team in a dynamic business focused on building and protecting reputation for clients”, said Chantelot. “Having partnered with executive leadership at some of the world’s most respected biopharmaceutical companies, I am eager to leverage my experience to further strengthen Burson’s client focus, capabilities and services, in healthcare and corporate advisory.”
About Burson
Burson is the global leader in communications purpose-built to create value for its clients through reputation. With highly specialized teams, industry-leading technologies and innovative creativity, Burson contributes to redefine the reputation of brands and companies as a competitive advantage, enabling them to lead both the present and in the future. Burson operates under WPP (NYSE: WPP), a creative transformation company. For more information, visit: www.bursonglobal.com.
